Cancer cell therapy study pulled before it began
NCT ID NCT06145802
First seen May 02, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study was designed to test an experimental treatment called GT316, which uses a patient's own immune cells (tumor-infiltrating lymphocytes) to fight advanced gynecological tumors. The goal was to see if the therapy was safe and could shrink tumors. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.